CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation

A. G.M. Stam, S. J.A.M. Santegoets, T. M. Westers, C. C. Sombroek, J. J.W.M. Janssen, B. W. Tillman, A. A. Van De Loosdrecht, H. M. Pinedo, D. T. Curiel, G. J. Ossenkoppele, R. J. Scheper, T. D. De Gruijl

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Vaccination with autologous leukaemia-derived dendritic cells (DC) presents an adjuvant treatment option for chronic myeloid leukaemia (CML). Here, we show that high-efficiency CD40-targeted adenoviral gene transfer of GM-CSF to CML-derived DC induces long-lived maturation in the absence of exogenous cytokines and may thus ensure protracted stimulation of CML-specific T cells upon vaccination.

Original languageEnglish
Pages (from-to)1162-1165
Number of pages4
JournalBritish Journal of Cancer
Volume89
Issue number7
DOIs
StatePublished - Oct 6 2003

Keywords

  • Adenovirus
  • CD40 ligation
  • CML
  • Dendritic cell
  • GM-CSF
  • Immunotherapy

Fingerprint

Dive into the research topics of 'CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation'. Together they form a unique fingerprint.

Cite this